These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8965061)

  • 41. G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone.
    Charalampopoulos I; Alexaki VI; Lazaridis I; Dermitzaki E; Avlonitis N; Tsatsanis C; Calogeropoulou T; Margioris AN; Castanas E; Gravanis A
    FASEB J; 2006 Mar; 20(3):577-9. PubMed ID: 16407456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
    Coelingh Bennink HJT; Zimmerman Y; Laan E; Termeer HMM; Appels N; Albert A; Fauser BCJM; Thijssen JHH; van Lunsen RHW
    Contraception; 2017 Nov; 96(5):322-329. PubMed ID: 27393080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DHEA replacement for postmenopausal women: placebo or panacea?
    Eden JA
    Climacteric; 2015; 18(4):439-40. PubMed ID: 25731680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gonadotropins stimulate growth of MCF-7 human breast cancer cells by promoting intracellular conversion of adrenal androgens to estrogens.
    Tanaka Y; Kuwabara K; Okazaki T; Fujita T; Oizumi I; Kaiho S; Ogata E
    Oncology; 2000; 59 Suppl 1():19-23. PubMed ID: 11096352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity.
    Aoki K; Terauchi Y
    Vitam Horm; 2018; 108():355-365. PubMed ID: 30029734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dehydroepiandrosterone (DHEA) and Aging. Proceedings of a conference. Washington, D.C., June 17-19, 1995.
    Ann N Y Acad Sci; 1995 Dec; 774():ix-xiv, 1-350. PubMed ID: 8597449
    [No Abstract]   [Full Text] [Related]  

  • 47. Dehydroepiandrosterone: a neuroactive steroid.
    Stárka L; Dušková M; Hill M
    J Steroid Biochem Mol Biol; 2015 Jan; 145():254-60. PubMed ID: 24704258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interrelationship between excessive levels of circulating androgens in blood and ovulatory failure.
    Parker CR; Mahesh VB
    J Reprod Med; 1976 Aug; 17(2):75-90. PubMed ID: 134158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Report on DHEA].
    Agence Francaise de Sécurité Sanitaire des Produits de Santé
    J Pharm Belg; 2001; 56(4):81-7. PubMed ID: 11565414
    [No Abstract]   [Full Text] [Related]  

  • 50. Intracrinology in action: importance of extragonadal sex steroid biosynthesis and inactivation in peripheral tissues in both women and men.
    Labrie F
    J Steroid Biochem Mol Biol; 2015 Jan; 145():131-2. PubMed ID: 25240498
    [No Abstract]   [Full Text] [Related]  

  • 51. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Dehydroepiandrosterone (DHEA)--slows down the aging process?].
    Uziebło-Zyczkowska B; Sidło E; Stelmaszuk T
    Pol Merkur Lekarski; 2005 Dec; 19(114):831-4. PubMed ID: 16521435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology.
    Labrie F; Martel C; Bélanger A; Pelletier G
    J Steroid Biochem Mol Biol; 2017 Apr; 168():9-18. PubMed ID: 28153489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DHEA: "miracle" drug?
    Kent S
    Geriatrics; 1982 Sep; 37(9):157-8, 161. PubMed ID: 6213449
    [No Abstract]   [Full Text] [Related]  

  • 55. Androgens and the brain.
    Genazzani AR; Pluchino N; Freschi L; Ninni F; Luisi M
    Maturitas; 2007 May; 57(1):27-30. PubMed ID: 17386983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal women.
    Labrie F; Bélanger A; Labrie C; Candas B; Cusan L; Gomez JL
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):57-69. PubMed ID: 17627814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Science of intracrinology in postmenopausal women.
    Labrie F; Bélanger A; Pelletier G; Martel C; Archer DF; Utian WH
    Menopause; 2017 Jun; 24(6):702-712. PubMed ID: 28098598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vitamins and endogenous regulatory factors].
    Eĭdel'man MM; Sharkevich IN
    Vopr Pitan; 1992; (1):11-6. PubMed ID: 1621370
    [No Abstract]   [Full Text] [Related]  

  • 59. Dehydroepiandrosterone-fatty acid esters in human plasma: formation, transport and delivery to steroid target tissues.
    Lavallée B; Provost PR; Roy R; Gauthier MC; Bélanger A
    J Endocrinol; 1996 Sep; 150 Suppl():S119-24. PubMed ID: 8943795
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dehydroepiandrosterone and its metabolites: differential effects on androgen receptor trafficking and transcriptional activity.
    Mo Q; Lu SF; Simon NG
    J Steroid Biochem Mol Biol; 2006 Apr; 99(1):50-8. PubMed ID: 16524719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.